Sterling Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Global leader in steroidal APIs
One of their notable products is HALOBETASOL PROPIONATE, with a corresponding US DMF Number 16861.
Remarkably, this DMF maintains an Active status since its submission on September 23, 2003, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of January 26, 2018, and payment made on December 29, 2017, indicating their dedication to facilitating drug approvals, Categorized as Type II